According to data released by the National Bureau of Statistics on the 18th, in 2022, the total investment in research and experimental development (RD) in China exceeded 3 trillion yuan, reaching 3078.29 billion yuan, reaching a new level; An increase of 10.1% compared to the previous year, continuing the trend of rapid growth. Zhang Qilong, a statistician from the Social Science and Literature Department of the National Bureau of Statistics, stated that in 2022, based on constant prices, China's RD funding increased by 7.7% compared to the previous year, which is higher than the target of the "14th Five Year Plan", which is to achieve an average annual increase of over 7% in R&D funding for the entire society. The increase in China's RD funding from 1 trillion yuan to 2 trillion yuan took 8 years, while the increase from 2 trillion yuan to 3 trillion yuan only took 4 years, fully reflecting the effectiveness of China's innovation driven development strategy in recent years. From the perspective of investment intensity, in 2022, the investment intensity of China's RD funds (the ratio of RD funds to GDP) was 2.54%, an increase of 0.11 percentage points compared to the previous year, the second highest increase in nearly 10 years. The intensity of RD funding investment ranks 13th in the world. Statistical data shows that the dominant position of enterprises has been further consolidated, and investment in key areas has continued to expand. In 2022, the contribution of enterprises to the growth of RD funds reached 84%, an increase of 4.6 percentage points compared to the previous year, which is the main force driving the growth of RD funds; The proportion of RD funding in the country is 77.6%, an increase of 0.7 percentage points compared to the previous year. New breakthroughs have been made in basic research investment, and the proportion continues to rise. In 2022, the growth rate of basic research funding is 1.3 percentage points faster than that of RD funding, continuing to maintain a rapid growth rate; The total amount exceeded 200 billion yuan for the first time, ranking second in the world in scale; The proportion of RD funding has reached 6.57%, continuing the upward trend. Zhang Qilong stated that overall, China's total RD funding and basic research investment have both reached a new level in 2022. In the next stage, on the one hand, we need to further improve the diversified investment mechanism of RD funds, increase financial support, expand the effectiveness of policies such as R&D expenditure tax exemptions, and improve financial support systems such as direct financing and guiding funds, and encourage local governments to continue increasing RD investment. On the other hand, it is necessary to focus on precise support for key technologies and key areas, continuously increase investment in basic research and achievement transformation, and focus on improving the efficiency of fund utilization. (New News Agency)